Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How do we manage hyperhemolysis syndrome.

Brian D Adkins1,2, Samer Z Kaylani2,3, Alecia Nero2,3,4

  • 1Division of Transfusion Medicine and Hemostasis, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Transfusion
|October 3, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Preoperative Therapeutic Plasma Exchange in Lupus Anticoagulant Hypoprothrombinemia Syndrome to Achieve Hemostatic Factor II Activity: A Case Report.

Journal of clinical apheresis·2026
Same author

AABB survey on directed blood donation practices.

Transfusion·2026
Same author

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
Same author

A survey of transfusion support strategies for passenger lymphocyte syndrome in minor ABO-mismatched allogeneic hematopoietic stem cell transplantation.

Transfusion·2026
Same author

A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial.

Trials·2026
Same author

Estimated Glomerular Filtration Rate Discordance and Cardiopulmonary Morbidity in Sickle Cell Disease.

Blood advances·2026

Hyperhemolysis syndrome (HHS) is a severe anemia after transfusion. This overview details diagnostic criteria and management strategies to optimize patient outcomes and reduce morbidity.

Area of Science:

  • Transfusion Medicine
  • Hematology

Background:

  • Hyperhemolysis syndrome (HHS) is a rare but severe complication following blood transfusions.
  • It involves the destruction of both donor and recipient red blood cells (RBCs), leading to significant morbidity and mortality.

Purpose of the Study:

  • To provide a detailed overview of a consensus-based treatment protocol for Hyperhemolysis syndrome.
  • To establish clear diagnostic criteria and management strategies for HHS.

Main Methods:

  • Collaboration among Transfusion Medicine and Hematology faculty to develop a consensus approach.
  • Review of contemporary literature and clinical experience.

Main Results:

  • Diagnostic criteria for HHS include recent transfusion, rapid hemoglobin decline (>25%), decreased HbA% (in specific anemias), low reticulocyte count with worsening anemia, and hemolysis evidence.
Keywords:
RBC transfusionhematology – red cellstransfusion complications‐non infectious

Related Experiment Videos

  • Management focuses on optimizing hematopoiesis and suppressing the immune response.

    • Conclusions:

    • A comprehensive approach to HHS diagnosis and management is presented.
    • This protocol aims to improve patient outcomes based on current evidence and clinical practice.